$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How many boxes of Ixazomib/Enleri are needed for one course of treatment? Full analysis of medication cycle
2026-02-01 22:25:32
Check Details
How much does rubicatin/rubitidin cost? Full analysis of price and cost performance
2026-02-01 22:25:32
Check Details
How long can I live after taking pirfenidone/Axri? Factors affecting prognosis and treatment effects
2026-02-01 22:25:32
Check Details
What type of drug does Canafenib belong to? Detailed explanation of indications and mechanism of action
2026-02-01 22:25:32
Check Details
What is the difference between Glasdegib/Glasdegib and Venekra?
2026-02-01 22:25:32
Check Details
Domestic market pricing and purchasing guide for DaliRasen tablets in various regions
2026-02-01 22:25:32
Check Details
Correct administration and dose adjustment guide for Lynparib/Olaparib
2026-02-01 22:25:32
Check Details
Detailed instructions for venetoclax/venetoclax: indications, usage, dosage and precautions
2026-02-01 22:25:32
Check Details
In which country was Assimini developed? Drug background and manufacturer revealed
2026-02-01 22:25:32
Check Details
Can I drink alcohol while taking ritexitinib? Analysis of the impact of alcohol on medicinal efficacy
2026-02-01 22:25:32
Check Details
How many years is most recommended for taking Glasdegib?
2026-02-01 22:25:32
Check Details
Evaluation of the effectiveness of sparsentan/sparsentan in the treatment of IgA nephropathy
2026-02-01 22:25:32
Check Details
1
2
...
1382
1383
1384
1385
1386
1387
1388
...
10212
10213
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Venetoclax (Venetoclax): Balancing Precision with Risk Management in Hematologic Malignancies
2
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
3
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
4
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
5
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
6
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
7
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
8
Vibegron 2026 Research Updates: New Evidence for Overactive Bladder Treatment
9
Elafibranor for Cholestatic Liver Diseases: Efficacy Maintenance and Drug Resistance Analysis
10
Benzgalantamine (Zunveyl) for Alzheimer's Disease: Efficacy and Optimal Treatment Stages
11
Loargys(Pegzilarginase-nbln) Complete Medication Guide: Pre-Treatment Assessment, Monitoring and Home Administration
12
Plerixafor Complete Side Effect Guide: Adverse Reaction Classification and Professional Management